Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Synapse

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 14515344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of a GABA transaminase inhibitor, γ-vinyl GABA, on voluntary morphine consumption in the rat

  2004cited by this paper
• Foggy visual field defect.

  2003cited by this paper
• Sub-chronic low dose γ-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine

  2003cited by this paper
• The legacy of vigabatrin in a regional epilepsy clinic

  2002cited by this paper
• Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: A prospective study

  2002cited by this paper
• Gamma‐vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine‐induced sensitization in male rats

  2002cited by this paper
• Reversed visual field constrictions in children after vigabatrin withdrawal--true retinal recovery or improved test performance only?

  2001cited by this paper
• Visual Field Loss Associated with Vigabatrin: Quantification and Relation to Dosage

  2001cited by this paper
• Gamma‐vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats

  2001cited by this paper
• Visual Function is Stable in Patients Who Continue Long‐Term Vigabatrin Therapy: Implications for Clinical Decision Making

  2001cited by this paper
• No reversion in vigabatrin-associated visual field defects

  2001cited by this paper
• Visual fields and tiagabine: a quandary.

  2001cited by this paper
• The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat.

  2001cited by this paper
• GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine.

  2001cited by this paper
• Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression.

  2001cited by this paper
• Increased mesolimbic GABA concentration blocks heroin self-administration in the rat.

  2000cited by this paper
• A controlled study of vigabatrin and visual abnormalities

  2000cited by this paper
• Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET/microdialysis study.

  2000cited by this paper
• Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.

  2000cited by this paper
• Visual field constriction is not limited to children treated with vigabatrin.

  1999cited by this paper
• The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats.

  1999cited by this paper
• A pharmacologic strategy for the treatment of nicotine addiction

  1999cited by this paper
• Gamma-vinyl gamma-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge.

  1999cited by this paper
• Implication of the GABAb receptor in gamma vinyl‐GABA's inhibition of cocaine‐induced increases in nucleus accumbens dopamine

  1999cited by this paper
• A novel strategy for the treatment of cocaine addiction

  1998cited by this paper
• Effects of pharmacologic increases in brain GABA levels on cocaine‐induced changes in extracellular dopamine

  1998cited by this paper
• Drug dependence study on vigabatrin in rhesus monkeys and rats.

  1997cited by this paper
• Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds

  1997cited by this paper
• Severe persistent visual field constriction associated with vigabatrin

  1997cited by this paper
• Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy

  1995cited by this paper
• Gamma-vinyl GABA decreases voluntary alcohol consumption in alcohol-preferring AA rats.

  1993cited by this paper
• GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography

  1992cited by this paper
• Possible retinotoxic effect of carbamazepine

  1986cited by this paper
• γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE 1

  1977cited by this paper

• Astrocytes: Role in pathogenesis and effect of commonly misused drugs in the HIV infected brain

  2023cites this paper
• Comparison of Treatments for Cocaine Use Disorder Among Adults

  2021cites this paper
• Drug addiction: from bench to bedside

  2021cites this paper
• Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes.

  2020cites this paper
• Effects of Isoniazid on Tolerance and Sensitization to the Rewarding Properties of Morphine: A Conditioned Place Preference Procedure Investigation in Mice

  2020cites this paper
• Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction.

  2018cites this paper
• Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions.

  2018cites this paper
• Acupuncture reduces relapse to cocaine‐seeking behavior via activation of GABA neurons in the ventral tegmental area

  2018cites this paper
• Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.

  2017cites this paper
• Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy

  2017cites this paper
• Treatment of Methamphetamine withdrawal in trauma patients

  2017cites this paper
• Developing Treatments for Stimulant Abuse: A Brief Overview.

  2016cites this paper
• A Novel Strategy for Attenuating Opioid Withdrawal in Neonates

  2016cites this paper
• Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy

  2015cites this paper
• Psychostimulants: Basic and Clinical Pharmacology.

  2015cites this paper
• Experiments with cocaine and heroin addicts--are they predictive?

  2014cites this paper
• GABA Levels in The Dorsal Anterior Cingulate Cortex Associated with Difficulty Ignoring Smoking-Related Cues in Tobacco-Dependent Volunteers

  2013cites this paper
• A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.

  2013cites this paper
• (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.

  2012cites this paper
• A Mouth-Watering Prospect: Salivation to Material Reward

  2012cites this paper
• Positron Emission Tomography Molecular Imaging of Dopaminergic System in Drug Addiction

  2012cites this paper
• The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

  2012cites this paper
• Agents in Development for the Management of Cocaine Abuse

  2012cites this paper
• Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

  2012cites this paper
• Pharmacological treatments for cocaine dependence: is there something new?

  2011cites this paper
• Hidden Markov models for zero‐inflated Poisson counts with an application to substance use

  2011cites this paper
• Addiction and brain reward and antireward pathways.

  2011cites this paper
• Opiates and plasticity.

  2011cites this paper
• Antiepileptic drugs in the treatment of psychiatric disorders.

  2011cites this paper
• New horizons for therapeutics in drug and alcohol abuse.

  2010cites this paper
• GABAB receptors in addiction and its treatment.

  2010cites this paper
• What’s New in the Treatment of Cocaine Addiction?

  2010cites this paper
• The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers.

  2009cites this paper
• Non-treatment laboratory stress- and cue-reactivity studies are associated with decreased substance use among drug-dependent individuals.

  2009cites this paper
• Pharmacotherapy of Addictive Disorders

  2009cites this paper
• Valproate treatment and cocaine cue reactivity in cocaine dependent individuals.

  2009cites this paper
• Cue-Induced Dopamine Release Predicts Cocaine Preference: Positron Emission Tomography Studies in Freely Moving Rodents

  2009cites this paper
• Anti-relapse medications: preclinical models for drug addiction treatment.

  2009influential citation
• Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.

  2009cites this paper
• Plasticity of addiction: a mesolimbic dopamine short-circuit?

  2009cites this paper
• Dusting New horizons for therapeutics in drug and alcohol abuse

  2009cites this paper
• Endocannabinoid Signaling Mediates Cocaine-Induced Inhibitory Synaptic Plasticity in Midbrain Dopamine Neurons

  2008cites this paper
• Candidate Medications for Stimulant Dependence MEDICATION Abstinence Initiation Medications Modafinil Propranolol Bupropion Relapse Prevention Medications GABA Enhancers

  2008cites this paper
• The Search for Medications to Treat Stimulant Dependence

  2008cites this paper
• Racemic gamma vinyl‐GABA (R,S‐GVG) blocks methamphetamine‐triggered reinstatement of conditioned place preference

  2008cites this paper
• Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats.

  2008cites this paper
• Use of animal models to develop antiaddiction medications

  2008cites this paper
• Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

  2008cites this paper
• Pilot Study of Lorazepam and Tiagabine Effects on Sleep, Motor Learning, and Impulsivity in Cocaine Abstinence

  2008cites this paper
• New treatments for cocaine dependence: a focused review.

  2008influential citation
• Tiagabine does not attenuate alcohol-induced activation of the human reward system

  2007cites this paper
• Targeting the treatment of drug abuse with molecular imaging.

  2007cites this paper
• Cocaine and Sleep: Early Abstinence

  2007cites this paper
• REVIEW: New developments in the pharmacotherapy of cocaine abuse

  2007cites this paper
• Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients.

  2007cites this paper
• Cellular and molecular mechanisms of drug dependence: An overview and update

  2007cites this paper
• 4 @bullet S C I E N C E & P R a C T I C E P E R S P E C T I V E S — a P R I L 2 0 0 7

  2007cites this paper
• Approaches to the development of medications for the treatment of methamphetamine dependence.

  2007cites this paper
• Imaging the Addicted Human Brain

  2007cites this paper
• Opioids block long-term potentiation of inhibitory synapses

  2007cites this paper
• Neue Entwicklungen in der Pharmakotherapie der Kokainabhängigkeit

  2006cites this paper
• Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia.

  2006cites this paper
• A formal [3,3]-sigmatropic rearrangement route to quaternary alpha-vinyl amino acids: use of allylic N-PMP trifluoroacetimidates.

  2006cites this paper
• [New developments in the pharmacotherapy of cocaine dependence].

  2006cites this paper
• Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence.

  2006cites this paper
• Effects of Baclofen on Cocaine Self-Administration: Opioid- and Nonopioid-Dependent Volunteers

  2006cites this paper
• α-Vinylic Amino Acids: Occurrence, Asymmetric Synthesis and Biochemical Mechanisms.

  2006cites this paper
• Critical assessment of how to study addiction and its treatment: human and non-human animal models.

  2005cites this paper
• Recent Advances in the Development of Treatments for Alcohol and Cocaine Dependence

  2005cites this paper
• Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.

  2005cites this paper
• Implications of chronic methamphetamine use: a literature review.

  2005cites this paper
• Imaging addiction with PET: is insight in sight?

  2005cites this paper
• New medications for the treatment of cocaine dependence.

  2005cites this paper
• Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences.

  2005cites this paper
• Anticraving medications for relapse prevention: a possible new class of psychoactive medications.

  2005cites this paper
• Smoked cocaine discrimination in humans: effects of gabapentin.

  2005cites this paper
• Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons

  2005cites this paper
• Recent Advances in the Pharmacotherapeutic Management of Drug Dependence and Addiction

  2005cites this paper
• Safety and efficacy of γ‐vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction

  2005influential citation
• Novel pharmacotherapeutic targets for the management of drug addiction.

  2005cites this paper
• Following an ISES lead: the first examples of asymmetric Ni(0)-mediated allylic amination.

  2004cites this paper
• Development of vigabatrin‐induced lesions in the rat brain studied by magnetic resonance imaging, histology, and immunocytochemistry

  2004cites this paper
• Role of γ‐Aminobutyric Acid (GABA) and Metabotropic Glutamate Receptors in Nicotine Reinforcement: Potential Pharmacotherapies for Smoking Cessation

  2004cites this paper
• Drug addiction: the neurobiology of behaviour gone awry

  2004cites this paper
• Dopamine in drug abuse and addiction: results from imaging studies and treatment implications

  2004cites this paper
• Gamma‐vinyl GABA (vigabatrin) blocks the expression of toluene‐induced conditioned place preference (CPP)

  2004influential citation
• Recent advances in the pharmacotherapy of cocaine dependence

  2004cites this paper
• Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans.

  2004cites this paper
• The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies.

  2004cites this paper
• Synthesis of quaternary amino acids bearing a (2'Z)-fluorovinyl alpha-branch: potential PLP enzyme inactivators.

  2004cites this paper
• Neurobiologic Processes in Drug Reward and Addiction

  2004cites this paper